Access, Watch, and Reserve antibiotics in India: challenges for WHO stewardship

The Lancet Global Health

Volumn 5, Issue 11, 2017, Pages e1075-e1076

  McGettigan, Patricia ^a   Roderick, Peter ^b   Kadam, Abhay ^c   Pollock, Allyson M ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c Lakshya Society for Public Health Education and Research   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN; CILASTATIN; CLAVULANIC ACID; COTRIMOXAZOLE; GLYCOPEPTIDE; IMIPENEM; MACROLIDE; PENEM DERIVATIVE; PIPERACILLIN; POLYMYXIN; QUINOLONE; TAZOBACTAM; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL STEWARDSHIP; DRUG COMBINATION; DRUG FORMULATION; HUMAN; INDIA; LETTER; PRESCRIPTION; PRIORITY JOURNAL; WORLD HEALTH ORGANIZATION; ORGANIZATION AND MANAGEMENT;

ANTI-BACTERIAL AGENTS; ANTIMICROBIAL STEWARDSHIP; HUMANS; INDIA; WORLD HEALTH ORGANIZATION;

EID: 85042198570     PISSN: None     EISSN: 2214109X     Source Type: Journal    
DOI: 10.1016/S2214-109X(17)30365-0     Document Type: Letter

References (6)

1. WHO. WHO model list of essential medicines. 20th list, March, 2017, World Health Organization, Geneva http://www.who.int/medicines/publications/essentialmedicines/20th_EML2017.pdf?ua=1 (accessed Sept 12, 2017).
2. WHO. Critically important antimicrobials for human medicine. 5th revision 2016, 2017, World Health Organization, Geneva http://apps.who.int/iris/bitstream/10665/255027/1/9789241512220-eng.pdf?ua=1 (accessed Sept 12, 2017).
3. WHO. Global action plan on antimicrobial resistance, 2015, World Health Organization, Geneva http://www.wpro.who.int/entity/drug_resistance/resources/global_action_plan_eng.pdf (accessed Sept 12, 2017).
4. O'Neill, J, Tackling drug-resistant infections globally: final report and recommendations. The review on antimicrobial resistance. http://amr-review.org/sites/default/files/160525_Final%20paper_with%20cover.pdf, May, 2016 (accessed Sept 12, 2017).
5. Department-Related Parliamentary Standing Committee on Health and Family Welfare. Fifty-ninth report on the functioning of the Central Drugs Standard Control Organization (CDSCO), May, 2012, Parliament of India, New Delhi http://164.100.47.5/newcommittee/reports/englishcommittees/committee%20on%20health%20and%20family%20welfare/59.pdf (accessed Sept 12, 2017).
6. McGettigan, P, Roderick, P, Mahajan, R, Kadam, A, Pollock, AM, Use of Fixed Dose Combination (FDC) drugs in India: central regulatory approval and sales of FDCs containing Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), metformin, or psychotropic drugs. PLoS Med, 12, 2015, e1001826.